WO1982004094A1
(en)
*
|
1981-05-19 |
1982-11-25 |
Leivenzon Simon |
Indicating means for a door operator device
|
DE68921934T2
(de)
*
|
1988-06-29 |
1995-10-19 |
Merck & Co Inc |
Immunsuppressives Agens.
|
US5290772A
(en)
*
|
1988-06-29 |
1994-03-01 |
Merck & Co., Inc. |
Immunosuppressant agent
|
ATE131536T1
(de)
*
|
1988-08-01 |
1995-12-15 |
Fujisawa Pharmaceutical Co |
Fr-901154- und fr-901155-derivate, verfahren zu ihrer herstellung
|
EP0356399A3
(de)
*
|
1988-08-26 |
1991-03-20 |
Sandoz Ag |
Substituierte 4-Azatricyclo (22.3.1.04.9) octacos-18-en-Derivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen
|
EP0358508A3
(de)
*
|
1988-09-08 |
1991-03-20 |
Merck & Co. Inc. |
Verbindung zur Unterdrückung der Immunabwehr
|
FR2639637A1
(fr)
*
|
1988-11-29 |
1990-06-01 |
Sandoz Sa |
Derives cycliques et leurs metabolites, leur preparation et leur utilisation comme medicaments
|
US4975372A
(en)
*
|
1989-01-13 |
1990-12-04 |
Merck & Co., Inc. |
Microbial transformation product of L-683,590
|
EP0378317A3
(de)
*
|
1989-01-13 |
1990-11-28 |
Merck & Co. Inc. |
Mikrobisches Umbildungsprodukt von L-679,934
|
US5268370A
(en)
*
|
1989-01-13 |
1993-12-07 |
Merck & Co., Inc. |
Microbial transformation product of L-679,934
|
EP0378320A3
(de)
*
|
1989-01-13 |
1990-11-28 |
Merck & Co. Inc. |
Mikrobielles Umwandlungsprodukt
|
EP0388153B1
(de)
*
|
1989-03-15 |
1994-12-28 |
Merck & Co. Inc. |
Immunosuppressives Mittel
|
CA2014841A1
(en)
*
|
1989-04-21 |
1990-10-21 |
Byron H. Arison |
Macrolides having immunosuppressive activity
|
US5068323A
(en)
*
|
1989-04-21 |
1991-11-26 |
Merck & Co., Inc. |
Thermally re-arranged FK-506 derivatives having immunosuppressant activity
|
CA2018710A1
(en)
*
|
1989-06-13 |
1990-12-13 |
Shieh-Shung T. Chen |
L-683,590 microbial transformation product
|
US5138052A
(en)
*
|
1989-06-13 |
1992-08-11 |
Merck & Co., Inc. |
L-683,590 microbial transformation product
|
KR920700212A
(ko)
*
|
1989-06-14 |
1992-02-19 |
쟝 크라머·한스 루돌프 하우스 |
헤테로원자-함유 트리사이클릭 화합물
|
US5200411A
(en)
*
|
1989-06-14 |
1993-04-06 |
Sandoz, Ltd. |
Heteroatoms-containing tricyclic compounds
|
EP0413532A3
(en)
*
|
1989-08-18 |
1991-05-15 |
Fisons Plc |
Macrocyclic compounds
|
WO1991002736A1
(en)
*
|
1989-08-18 |
1991-03-07 |
Fisons Plc |
Macrocyclic compounds
|
GR1001225B
(el)
*
|
1989-09-14 |
1993-06-30 |
Fisons Plc |
Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους.
|
KR0159766B1
(ko)
*
|
1989-10-16 |
1998-12-01 |
후지사와 토모키치로 |
양모제 조성물
|
US5215995A
(en)
*
|
1989-10-16 |
1993-06-01 |
Fujisawa Pharmaceutical Co., Ltd. |
Hair revitalizing agent
|
ATE126803T1
(de)
*
|
1989-11-09 |
1995-09-15 |
Sandoz Ag |
Heteroatome enthaltende tricyclische verbindungen.
|
US5352671A
(en)
*
|
1989-11-09 |
1994-10-04 |
Sandoz Ltd. |
Heteroatoms-containing tricyclic compounds
|
IE904050A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Merck & Co Inc |
Aminomacrolides and derivatives having immunosuppressive¹activity
|
US5208228A
(en)
*
|
1989-11-13 |
1993-05-04 |
Merck & Co., Inc. |
Aminomacrolides and derivatives having immunosuppressive activity
|
GB8925797D0
(en)
*
|
1989-11-15 |
1990-01-04 |
Fisons Plc |
Compositions
|
EP0444829A3
(en)
*
|
1990-02-27 |
1992-06-03 |
Fisons Plc |
Immunosuppressive compounds
|
US5064835A
(en)
*
|
1990-03-01 |
1991-11-12 |
Merck & Co., Inc. |
Hydroxymacrolide derivatives having immunosuppressive activity
|
US5260301A
(en)
*
|
1990-03-01 |
1993-11-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Pharmaceutical solution containing FK-506
|
EP0594600A1
(de)
*
|
1990-03-13 |
1994-05-04 |
FISONS plc |
Immunosuppressive makrozyklische verbindungen
|
US5296489A
(en)
*
|
1990-03-13 |
1994-03-22 |
Fisons |
Immunosuppressive macrocyclic compounds
|
EP0455427A1
(de)
*
|
1990-04-30 |
1991-11-06 |
Merck & Co. Inc. |
Deoxyaycrolid-Derivate mit immunsuppressiver Wirkung
|
JPH05507915A
(ja)
*
|
1990-06-11 |
1993-11-11 |
藤沢薬品工業株式会社 |
特発性血小板減少性紫斑病およびバセドウ病治療薬製造のためのfk506等のマクロライド化合物の用途
|
US5643901A
(en)
*
|
1990-06-11 |
1997-07-01 |
Fujisawa Pharmaceutical Co., Ltd. |
Medicament for treating idiopathic thrombocytopenic purpura
|
US5190950A
(en)
*
|
1990-06-25 |
1993-03-02 |
Merck & Co., Inc. |
Antagonists of immunosuppressive macrolides
|
GB9014136D0
(en)
*
|
1990-06-25 |
1990-08-15 |
Fujisawa Pharmaceutical Co |
Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same
|
US5342935A
(en)
*
|
1990-06-25 |
1994-08-30 |
Merck & Co., Inc. |
Antagonists of immunosuppressive macrolides
|
CA2044846A1
(en)
*
|
1990-06-25 |
1991-12-26 |
Thomas R. Beattie |
Antagonists of immunosuppressive macrolides
|
US5210030A
(en)
*
|
1990-06-25 |
1993-05-11 |
Merck & Co., Inc. |
Process for selectively acylating immunomycin
|
MY110418A
(en)
*
|
1990-07-02 |
1998-05-30 |
Novartis Ag |
Heteroatoms-containing tricyclic compounds.
|
GB9014681D0
(en)
*
|
1990-07-02 |
1990-08-22 |
Fujisawa Pharmaceutical Co |
Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same
|
EP0466365A3
(en)
|
1990-07-03 |
1992-04-15 |
Merck & Co. Inc. |
Novel immunosuppressant fermentation products of a microorganism
|
GB9014881D0
(en)
*
|
1990-07-05 |
1990-08-22 |
Fujisawa Pharmaceutical Co |
Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same
|
GB2245561A
(en)
*
|
1990-07-05 |
1992-01-08 |
Fujisawa Pharmaceutical Co |
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
|
US5023263A
(en)
*
|
1990-08-09 |
1991-06-11 |
American Home Products Corporation |
42-oxorapamycin
|
US5023262A
(en)
*
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
WO1992003441A1
(en)
*
|
1990-08-18 |
1992-03-05 |
Fisons Plc |
Macrocyclic compounds
|
GB2247620A
(en)
*
|
1990-09-07 |
1992-03-11 |
Fujisawa Pharmaceutical Co |
The use of macrolide compounds for cytomegalovirus infection
|
US5143918A
(en)
*
|
1990-10-11 |
1992-09-01 |
Merck & Co., Inc. |
Halomacrolides and derivatives having immunosuppressive activity
|
EP0480623A1
(de)
*
|
1990-10-11 |
1992-04-15 |
Merck & Co. Inc. |
Halomakrolide und Derivate mit immunosuppressiver Wirkung
|
GB2249027A
(en)
*
|
1990-10-23 |
1992-04-29 |
Fujisawa Pharmaceutical Co |
Use of macrolide compounds for hepatic failure
|
US5348966A
(en)
*
|
1990-10-24 |
1994-09-20 |
Fujisawa Pharmaceutical Co., Ltd. |
Method for treating pyoderma and Sezary's syndrome using FK 506 and related compounds
|
CA2054128A1
(en)
*
|
1990-10-29 |
1992-04-30 |
Kevin M. Byrne |
Process for the production of analogues of immunomycin
|
PH31204A
(en)
*
|
1990-11-02 |
1998-05-05 |
Fujisawa Pharmaceutical Co |
Pharmaceutical composition.
|
IE65341B1
(en)
*
|
1990-11-08 |
1995-10-18 |
Fujisawa Pharmaceutical Co |
Suspensions containing tricyclic compounds
|
GB2249787A
(en)
*
|
1990-11-19 |
1992-05-20 |
Fujisawa Pharmaceutical Co |
Lactone compounds
|
GB9027471D0
(en)
*
|
1990-12-19 |
1991-02-06 |
Fujisawa Pharmaceutical Co |
Novel compound
|
GB2252041A
(en)
*
|
1991-01-23 |
1992-07-29 |
Fujisawa Pharmaceutical Co |
Use of macrolide compounds in treatment of autoimmune myocarditis
|
WO1992013862A1
(en)
*
|
1991-02-05 |
1992-08-20 |
Fujisawa Pharmaceutical Co., Ltd. |
Lactone compounds
|
WO1992018506A1
(en)
*
|
1991-04-11 |
1992-10-29 |
Pfizer, Inc. |
Novel immunosuppressant agent from streptomyces braegensis
|
DK0581959T3
(da)
*
|
1991-04-26 |
2001-01-29 |
Fujisawa Pharmaceutical Co |
Anvendelse af makrolidforbindelser til øjensygdomme
|
US5162334A
(en)
*
|
1991-05-13 |
1992-11-10 |
Merck & Co., Inc. |
Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
|
US5250678A
(en)
|
1991-05-13 |
1993-10-05 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
|
US5565560A
(en)
*
|
1991-05-13 |
1996-10-15 |
Merck & Co., Inc. |
O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
|
CA2071332A1
(en)
*
|
1991-06-25 |
1992-12-26 |
Laszlo R. Treiber |
C-21 hydroxylated fk-506 antagonist
|
US5225403A
(en)
*
|
1991-06-25 |
1993-07-06 |
Merck & Co., Inc. |
C-21 hydroxylated FK-506 antagonist
|
US5198358A
(en)
*
|
1991-08-28 |
1993-03-30 |
Merck & Co., Inc. |
Microorganism for producing C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent
|
US5149701A
(en)
*
|
1991-08-01 |
1992-09-22 |
Merck & Co., Inc. |
C-31 methylated FR-900520 cyclic hemiketal immunosuppressant agents
|
US5273979A
(en)
*
|
1991-08-01 |
1993-12-28 |
Merck & Co., Inc. |
C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent
|
US5189042A
(en)
*
|
1991-08-22 |
1993-02-23 |
Merck & Co. Inc. |
Fluoromacrolides having immunosuppressive activity
|
US5708002A
(en)
*
|
1991-09-05 |
1998-01-13 |
Abbott Laboratories |
Macrocyclic immunomodulators
|
KR100351222B1
(ko)
*
|
1991-09-05 |
2002-09-05 |
아보트 러보러터리즈 |
매크로사이클릭 면역 조절제 및 이의 제조방법
|
US5252732A
(en)
*
|
1991-09-09 |
1993-10-12 |
Merck & Co., Inc. |
D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
|
US5208241A
(en)
*
|
1991-09-09 |
1993-05-04 |
Merck & Co., Inc. |
N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
|
ZA926812B
(en)
|
1991-09-09 |
1993-04-28 |
Merck & Co Inc |
O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
|
US5817333A
(en)
*
|
1991-10-31 |
1998-10-06 |
Fujisawa Pharmaceutical Co., Ltd. |
Liposome preparation containing a tricyclic compound
|
US5164399A
(en)
*
|
1991-11-18 |
1992-11-17 |
American Home Products Corporation |
Rapamycin pyrazoles
|
US5221625A
(en)
*
|
1992-01-10 |
1993-06-22 |
Merck & Co., Inc. |
Cyclcic FR-900520 microbial biotransformation agent
|
GB9203265D0
(en)
*
|
1992-02-15 |
1992-04-01 |
Fisons Plc |
Pharmaceutically active compound
|
JP2563080B2
(ja)
*
|
1992-03-02 |
1996-12-11 |
フアイザー・インコーポレイテツド |
マクロライドの糖誘導体
|
CA2091194A1
(en)
*
|
1992-04-08 |
1993-10-09 |
Richard D. Connell |
2-oxo-ethyl derivatives as immunosuppressants
|
US5284840A
(en)
*
|
1992-06-12 |
1994-02-08 |
Merck & Co., Inc. |
Alkylidene macrolides having immunosuppressive activity
|
US5284877A
(en)
*
|
1992-06-12 |
1994-02-08 |
Merck & Co., Inc. |
Alkyl and alkenyl macrolides having immunosuppressive activity
|
US5264355A
(en)
*
|
1992-07-02 |
1993-11-23 |
Merck & Co., Inc. |
Methlating enzyme from streptomyces MA6858
|
GB9218027D0
(en)
*
|
1992-08-25 |
1992-10-14 |
Fisons Plc |
Novel method of treatment
|
GB9218597D0
(en)
*
|
1992-08-25 |
1992-10-14 |
Fisons Plc |
Novel method of treatment
|
GB9218797D0
(en)
*
|
1992-09-04 |
1992-10-21 |
Fisons Plc |
Pharmacologically active compounds
|
CA2106034A1
(en)
*
|
1992-09-24 |
1994-03-25 |
Ralph J. Russo |
21-norrapamycin
|
US5268281A
(en)
*
|
1992-09-28 |
1993-12-07 |
Merck & Co., Inc. |
Cyclic FR-900520 microbial biotransformation agent
|
US5268282A
(en)
*
|
1992-09-28 |
1993-12-07 |
Merck & Co., Inc. |
Cyclic FR-900520 microbial biotransformation agent
|
US5290689A
(en)
*
|
1992-09-28 |
1994-03-01 |
Merck & Co., Inc. |
New cyclic FR-900520 microbial biotransformation agent
|
US5283183A
(en)
*
|
1992-09-28 |
1994-02-01 |
Merck & Co., Inc. |
Cyclic FR-900520 microbial biotransformation agent
|
US5258389A
(en)
*
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
DE69326015T2
(de)
*
|
1992-11-18 |
2000-02-03 |
Fujisawa Pharmaceutical Co |
Pharmazeutische zubereitung mit verlängerter wirkung
|
GB9227055D0
(en)
*
|
1992-12-29 |
1993-02-24 |
Fujisawa Pharmaceutical Co |
New use
|
US5310901A
(en)
*
|
1993-03-05 |
1994-05-10 |
Merck & Co., Inc. |
O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynlheteroarylrapamycin derivatives
|
US5310903A
(en)
*
|
1993-03-05 |
1994-05-10 |
Merck & Co., Inc. |
Imidazolidyl rapamycin derivatives
|
GB2279006A
(en)
*
|
1993-06-03 |
1994-12-21 |
Fujisawa Pharmaceutical Co |
Treatment of amyotrophic lateral sclerosis
|
US5359060A
(en)
*
|
1993-07-06 |
1994-10-25 |
Pfizer, Inc. |
Phosponated derivatives of macrolides
|
US5612350A
(en)
*
|
1993-11-30 |
1997-03-18 |
Abbott Laboratories |
Macrocyclic immunomodulators with novel cyclohexyl ring replacements
|
US5880280A
(en)
*
|
1994-06-15 |
1999-03-09 |
Merck & Co., Inc. |
Aryl, alkyl, alkenyl and alkynylmacrolides having immunosuppressive activity
|
US5693648A
(en)
*
|
1994-09-30 |
1997-12-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
|
CN1089233C
(zh)
|
1994-10-26 |
2002-08-21 |
诺瓦蒂斯有限公司 |
药物组合物
|
AR004480A1
(es)
*
|
1995-04-06 |
1998-12-16 |
Amico Derin C D |
Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
|
EP2198858B1
(de)
|
1998-03-26 |
2011-06-29 |
Astellas Pharma Inc. |
Retardpräparat mit Makroliden wie Tacrolimus
|
US6503737B1
(en)
*
|
1998-10-02 |
2003-01-07 |
Kosan Biosciences, Inc. |
Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster
|
GB9826656D0
(en)
|
1998-12-03 |
1999-01-27 |
Novartis Ag |
Organic compounds
|
US7063857B1
(en)
|
1999-04-30 |
2006-06-20 |
Sucampo Ag |
Use of macrolide compounds for the treatment of dry eye
|
US20070032853A1
(en)
|
2002-03-27 |
2007-02-08 |
Hossainy Syed F |
40-O-(2-hydroxy)ethyl-rapamycin coated stent
|
US7807211B2
(en)
|
1999-09-03 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Thermal treatment of an implantable medical device
|
US6790228B2
(en)
|
1999-12-23 |
2004-09-14 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
US6569867B2
(en)
|
1999-10-01 |
2003-05-27 |
Kosan Biosciences, Inc. |
Polyketide derivatives
|
AR035411A1
(es)
*
|
2000-12-29 |
2004-05-26 |
Fujisawa Pharmaceutical Co |
Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto
|
KR100512021B1
(ko)
*
|
2002-07-25 |
2005-09-02 |
신득용 |
Fk506을 이용한 세포의 노화를 억제하는 방법 및 배양배지
|
AU2003901023A0
(en)
*
|
2003-03-04 |
2003-03-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New use
|
US20050118344A1
(en)
|
2003-12-01 |
2005-06-02 |
Pacetti Stephen D. |
Temperature controlled crimping
|
WO2005067928A1
(en)
*
|
2004-01-20 |
2005-07-28 |
Astellas Pharma Inc. |
Method for treating erectile dysfunction
|
EP1860438B1
(de)
|
2005-08-12 |
2009-11-18 |
Astellas Pharma Inc. |
Verfahren zur identifizierung des zielproteins eines wirkstoffs und verfahren zum screening eines therapeutischen wirkstoffs gegen diabetes mittels des zielproteins
|
JP2009203162A
(ja)
*
|
2006-06-05 |
2009-09-10 |
Astellas Pharma Inc |
マクロライド化合物の新規製造法
|
CA2660804A1
(en)
|
2006-08-31 |
2008-03-06 |
Astellas Pharma Inc. |
Reverse targeting lipid vesicle
|
TW200932240A
(en)
|
2007-10-25 |
2009-08-01 |
Astellas Pharma Inc |
Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
|
EP2658855A2
(de)
|
2010-12-31 |
2013-11-06 |
Acies Bio d.o.o. |
Neue polyketidverbindungen und verfahren zu ihrer herstellung
|
EP2567959B1
(de)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren
|
US10143682B2
(en)
|
2014-10-28 |
2018-12-04 |
Koushi Yamaguchi |
Medicine for improving state of pregnancy, and use thereof
|
CN106074367A
(zh)
*
|
2016-07-20 |
2016-11-09 |
中山大学中山眼科中心 |
含fk506类化合物/fkbp蛋白二聚体的药物组合物及其制备方法
|
KR20190075120A
(ko)
|
2016-11-10 |
2019-06-28 |
노파르티스 아게 |
Bmp 강화제
|
US20210228551A1
(en)
|
2018-08-10 |
2021-07-29 |
Koushi Yamaguchi |
Therapeutic agent for humoral immunity-related diseases in maternofetal relationship
|
WO2020129348A1
(ja)
|
2018-12-18 |
2020-06-25 |
晃史 山口 |
不妊・不育症または妊娠状態を改善するための薬剤
|